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CARDIOTHORACIC SURGICAL EDUCATION AND TRAININGCardiothoracic surgery and the National Institutes of Health and
National Heart, Lung, and Blood InstituteDamien J. LaPar, MD, and Irving L. Kron, MDOver the past several years, the American Association for
Thoracic Surgery (AATS) Council and its Scientific and
Government Relations Committee have wrestled with
the significant reduction in funding support for cardiotho-
racic (CT) surgeons from the National Institutes of Health
(NIH) and the National Heart, Lung, and Blood Institute
(NHLBI). Translational research is the lifeblood of our
specialty, and the Council is committed to expanding the
specialty’s involvement at the national level.
In early August 2010, the NHLBI’s Division of Cardiovas-
cular Sciences invited current AATS leadership to present at
the Visiting Scholar Lectureship program. This forum af-
forded an excellent opportunity to sharewithDrSusanShurin,
the Acting Director of the NHLBI, and approximately 30 of
her professional staff the importance of a special relationship
between the field of CT surgery and the NIH and NHLBI.
We present the vital role CT surgery plays in the Ameri-
can Public Health System, the history and contributions the
NIH and NHLBI have provided to the advancement of CT
surgery, and the unique role CT surgeons play in transla-
tional research. We comment on recent trends in NIH and
NHLBI funding success rates of CT surgeons and provide
insight into future prospects for CT research funding.
AMERICAN PUBLIC AND PUBLIC HEALTH
SERVICE
The field of CT surgery significantly benefits the Ameri-
can public and plays a vital role in the American public
health system. According to the Centers for Disease Con-
trol, cardiovascular and thoracic-related diseases remain
the leading causes of death in the United States, with heart
disease ranking as number one and lung cancer serving as
the principal cause of cancer-related deaths.1 Surgical treat-
ment for cardiac and pulmonary disease, therefore, remains
of primary importance to the American health system.
In 2008, more than 207,000 coronary artery bypass graft-
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20 The Journal of Thoracic and Cardiovascular SurgeStates, whereas approximately 102,795 cardiac valve
operations and more than 85,000 pulmonary resections
were noted within the Agency for Healthcare Research
and Quality’s Nationwide Inpatient Sample database.2 Al-
though it is well known that CABG operative volume has
declined in recent times, the volume of cardiac valve oper-
ations has remained relatively stable (Figure 1).2 Neverthe-
less, CABG still remains one of the most common
operations within the United States, and the surgical correc-
tion of structural cardiac valve disease is of primary impor-
tance to our patients.
CT surgical procedures account for a significant propor-
tion of total US health expenditures. Recent estimates from
the American Heart Association and NHLBI indicate that
the total costs of cardiovascular disease in the United States
for 2009 was $475.3 billion.3 Furthermore, according to the
Agency for Healthcare Research and Quality 2008 national
statistics, among a total of 231 principal procedure cate-
gories, cardiac procedures alone accounted for 4 of the
top 15 procedures with respect to total health expenditures
in the United States (Table 1).2 These estimates not only
highlight the significant burden of CT disease within con-
temporary surgical practice but also illustrate the relative
importance of CT surgical treatment to the American public
in current times.
In light of these findings, certain truths emerge. In mod-
ern times, CT surgery is common and remains necessary for
American patients. In fact, with an increasing elderly pop-
ulation and prevalence of cardiovascular and thoracic
disease, an increasing proportion of US patients are likely
to require CT surgical procedures. CT surgery consumes
a large proportion of total US health expenditures, and
this impact is likely to increase in the not too distant future.
Consequently, scientifically justified improvements in CT
surgical procedures and technology continue to provide
great benefit to society.HISTORY OF CARDIOTHORACIC RESEARCH
AND THE ROLE OF THE NATIONAL INSTITUTES
OF HEALTH AND NATIONAL HEART, LUNG, AND
BLOOD INSTITUTE
Surgical and CT surgical research have played funda-
mental roles in the history of American medicine. Further,
the role of the surgeon-scientist remains challenging and
critical to their success and advancement. As Francis D.
Moore, MD, the iconic Peter Bent Brigham Hospital
Surgeon-in-Chief, once remarked ‘‘the surgical investigatorry c July 2011
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logical science to he patient’s bedside and back again. He
traces his origins from both ends of the bridge, he is thus
a bastard, and everyone calls him this. Those at one end
of the bridge say that he is not a very good scientist, and
those at the other end say he does not spend enough time
in the operating room.’’ This insight underscores the key
role that surgical research has played historically and de-
fines the increasing challenges that the modern day
surgeon-scientist faces daily.
Historically, CT research has played an integral role in
the advancement of medicine and science. Through the
pioneering efforts of CT surgical giants, including John
H. Gibbon, MD, and C. Walton Lillehei, MD, the develop-
ment and implementation of contemporary cardiopulmo-
nary bypass technology have transformed the practice of
adult and congenital cardiac surgery into a realistic possibil-
ity for patients worldwide that, in most cases, is associated
with low mortality and significant efficacy. In addition, im-
portant advances in myocardial protection, the development
and refinement of prosthetic cardiac valves for implanta-
tion, and the design and implementation of ventricular assist
device technology have transformed CT surgical practice to
provide surgeons with a broad armamentarium to combat
most functional and structural cardiac disease.
The NIH and NHLBI have played a key role in the
advancement of CT surgery research. Whether through
the direct intramural support of the development and im-
plantation of the first artificial human mitral valve by
Nina Starr Braunwald, MD, in her landmark operation in
1960, the establishment of the National Heart Institute’s
Clinic of Surgery, or the extramural support of CT research,
the importance of the relationship between the academic CT
surgical community and the NIH and NHLBI cannot be em-
phasized enough. For 37 years (1953–1990), the NIH
Surgery Branch along with the National Heart Institute’s
Clinic of Surgery mentored and trained 170 of today’s
surgeons, many of whom are academic leaders of contem-
porary US surgery.
Approximately 30% of these trainees have achieved the
position of Division Chief or Department Chair. Thus, di-
rect NIH support has produced a veritable ‘‘Who’s Who’’The Journal of Thoracic and Cof CT surgery during the latter part of the 20th century.
The eventual closure of the NIH Clinic of Surgery and the
NHLBI cardiac surgery program in 1990 seemed to be a sig-
nificant step back for the field of CT surgical research. How-
ever, in 1990, the acting director of the NHLBI, Claude
L’Enfant, MD, addressed many of these concerns with his
commitment to the academic CT surgical community:
‘‘The decision to close the cardiac surgery program at
NHLBI was difficult in that it reduced the opportunity to
train academic thoracic surgeons. The emphasis would be
shifted towards expanding and creating new programs that
would assist the Institute in remaining in the forefront of
CT research and allow for the training of surgical investiga-
tors.’’4 Thus, the dawn of a new horizon for NIH and
NHLBI extramural support for the training of new CT sur-
gical investigators seemed eminent. This did not occur. De-
spite such commitment, there exist only 2 active extramural
NIH T32-sponsored CT surgery training grants in the coun-
try today.
Extramural NIH and NHLBI support for CT research has
proven vital and remains essential to the academic CT surgi-
cal community and patients worldwide. The current NHLBI
Strategic Plan emphasizes translational research as a vital
part of the Institute’s mission, and current NIH and NHLBI
fundingofCTsurgerywill continue to promote important ad-
vances in translational research to enhance patient outcomes
and care. Current NHLBI-supported efforts in CT transla-
tional research continue to result in important discoveries
in the areas of cardiopulmonary bypass, beating heart sur-
gery, cardiac arrhythmia surgery, myocardial protection,
heart and lung transplantation, aortic aneurysms, chronic or-
gan rejection, ventricular assist devices, and congenital heart
surgery. Despite these advances, however, the success rates
for CT surgeons to obtain NIH and NHLBI funding support
have declined in recent times, and CT surgeon investigators
seem to face an evenmoredifficult set of circumstances in the
face of looming economic uncertainty. Complicating the sit-
uation even further is the apparent discordance with an in-
creasing need for CT surgical advancement and the
declining number of CT surgical applicants to carry forward
the academic mission and obligation of our field.
NATIONAL INSTITUTES OF HEALTH SUCCESS
RATES FOR CARDIOTHORACIC SURGEONS AND
CURRENT FUNDING OPPORTUNITIES
One of the most alarming realities for the contemporary
CT surgical investigator is the increasing difficulty in ob-
taining NIH extramural support for new and continuing sur-
gical research. In an effort to further understand the driving
forces behind such trends, a recent investigation by Rat-
cliffe and colleagues5 addressed the current status of NIH
funding for CT surgical research. In their analyses, they
determined that although, overall, the number of NIH appli-
cations for research funding has dramatically increased inardiovascular Surgery c Volume 142, Number 1 21
FIGURE 1. A, CABG operative volumewithin the United States from 2002 to 2007. B, Cardiac valve procedure volumewithin the United States from 2003
to 2007.
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tively constant. They noted similar trends for surgical re-
search applications as a whole, as well as among CT
surgery as a subspecialty. However, most concerning was
their findings that per capita NIH funding of CT surgeons
has disproportionately declined since about 2003. They
cited the principal reason for this decline being the low
per capita number of CT surgery research applications,
and they suggested that affirmative action from the NIH fa-
voring funding for CT research may be necessary. In an ed-
itorial response to this report, John E. Niederhauser, MD,
from the National Cancer Institute, argued against an affir-
mative action approach and asserted that the responsibility
to procure research funding should be that of the leadership
of American surgery and the surgeon investigator in concert
with institutional and departmental support.6 Unfortunately,
this approach is not possible.
US academic medical centers and departments do not
have the financial resources to support surgeon investigators
alone, and the American CT surgical leadership has madeTABLE 1. Mean charges and rank with respect to total health
expenditures for cardiothoracic surgery procedures within the
United States
Principal procedure category*
Charges
(mean) SEM Ranky
Cardiopulmonary bypass use $475,918 $38,303 1
Heart valve procedures $161,838 $34,144 6
CABG $117,094 $4451 9
Other cardiac procedures $42,104 $7284 15
SEM, Standard error of the mean; CABG, coronary artery bypass grafting. *Based on
Clinical Classifications Software principal procedure categories for International
Classification of Disease, 9th Revision, Clinical Modification codes as reported
within HCUP Nationwide Inpatient Sample datasets. yRank number of 231 total
possible Clinical Classifications Software categories.
22 The Journal of Thoracic and Cardiovascular Surgesignificant efforts in recent times to support innovative
CT surgical research. Through the joint efforts of the
AATS, the Society of Thoracic Surgeons, and the Thoracic
Surgery Foundation for Research and Education, several
research-based initiatives have been developed and pro-
moted, including multiple research scholarships and fellow-
ships, sponsored courses on research and funding, and
awards for outstanding research. However, these opportuni-
ties exist through private sponsorship and donations and are
insufficient to meet the demands of current and future CT
research needs.FUTURE PROSPECTS FOR CARDIOTHORACIC
SURGERY FUNDING
Despite inherent difficulties, there exist several avenues
to improve the future of CT surgery research and funding
support. Currently, there are 3 major issues facing the CT
surgeon investigator: (1) CT surgery grant applications
are not being reviewed by peers; (2) there is a need for in-
creased CT surgery research training programs; and (3)
there is a decrease in CT research funding. As a result,
some of the NHLBI leadership has expressed their desire
to promote a Program Announcement with Review to be es-
tablished under the auspices of the NHLBI. Although fund-
ing through this process would not be allocated specifically
for CT research, this process would ensure that NIH and
NHLBI grant applications (RO1s) would be reviewed and
scored by the NHLBI Review Board. To take full advantage
of these opportunities, all grant applications to the NIH
Center for Scientific Review should specifically request
that CT surgeons sit on the review panel. In addition, the ex-
isting NIH-sponsored T24 early stage investigator award
may be an avenue that CT surgeon investigators might pur-
sue for additional research training opportunities, and thery c July 2011
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currently evaluating methods to expand new research train-
ing award mechanisms, similar to those currently used by
vascular surgery training program. The NHLBI is currently
planning a working group to discuss future directions in car-
diac surgery research and the participation of organizations,
such as the AATS and Society of Thoracic Surgeons, in de-
veloping this initiative. Moreover, there should be more at-
tention focused on multidisciplinary collaboration on
clinical trials among CT surgery and other specialties, be-
cause this is a primary value of the NHLBI. The CT Surgery
Network, sponsored by the NHLBI, is an example of this
effort.
CONCLUSIONS
The issues surrounding the funding difficulties facing con-
temporary CT surgical investigators are real, complex, and
daunting. Although, the NIH and NHLBI have done much
to supportCTresearch in the past, it is apparent that the future
of CT research funding remains the responsibility of the ac-
ademic CT surgical community and the NIH and NHLBI. In
response to declining NIH funding success rates in recent
times, the American CT surgical leadership has made signif-
icant efforts to narrow the gap that exists between required
and awarded funding for CT surgical research. The NIHThe Journal of Thoracic and Cand NHLBI have made some efforts, through the Clinical
andTranslational ScienceAward program and theUO1path-
way available from NHLBI Centers for Cardiovascular Out-
comes Research. However, as a whole, NIH and NHLBI
opportunities are limited at present but show significant
promise in the future with continued interaction and collab-
oration with the NIH and NHLBI. In the end, CT surgery re-
mains critical to the future needs of theAmerican public, and
the NIH and NHLBI in partnership with CT leadership have
an obligation to promote translational efforts to improve the
healthcare of the American public.References
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